CIPLA
Back to Income Statement
|
CIPLA Last 5 Year Operating Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Operating Profit (Excl OI) | ₹6,291 Cr | ₹4,990 Cr | ₹4,512 Cr | ₹4,249 Cr | ₹3,181 Cr |
What is the latest Operating Profit of CIPLA ?
Year | Operating Profit |
---|---|
Mar2024 | ₹6,291 Cr |
Mar2023 | ₹4,990 Cr |
Mar2022 | ₹4,512 Cr |
Mar2021 | ₹4,249 Cr |
Mar2020 | ₹3,181 Cr |
How is Operating Profit of CIPLA Trending?
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2024 | ₹6,291 Cr | 26.07 | |
Mar2023 | ₹4,990 Cr | 10.60 | |
Mar2022 | ₹4,512 Cr | 6.20 | |
Mar2021 | ₹4,249 Cr | 33.57 | |
Mar2020 | ₹3,181 Cr | - |
Compare Operating Profit of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹133,407.4 Cr | -0.3% | 5.7% | 36.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹439,714.0 Cr | -1.7% | 3.8% | 62.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹145,166.0 Cr | -0.2% | 15.8% | 45.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,604.0 Cr | -1.7% | -5.7% | 15.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹108,608.0 Cr | -3.6% | -9.5% | 72.6% | Stock Analytics | |
MANKIND PHARMA | ₹96,024.4 Cr | -1.5% | 1.6% | 35.5% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | -0.3% |
5.7% |
36.1% |
SENSEX | 1.8% |
3.1% |
23.4% |
You may also like the below Video Courses